Please Wait
Applying Filters...
menu
    • menu
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Taurolidine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CorMedix Announces Agreement With Mid-Sized Dialysis Operator
    CorMedix Announces Agreement With Mid-Sized Dialysis Operator

    08 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/en/news-release/2024/10/08/2959640/0/en/CorMedix-Announces-New-Commercial-Agreement-with-Mid-Sized-Dialysis-Operator.html

    GLOBENEWSWIRE
    08 Oct 2024
    Share Share
    CorMedix Inc. Announces New Commercial Agreement
    CorMedix Inc. Announces New Commercial Agreement

    19 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/19/2948961/0/en/CorMedix-Inc-Announces-New-Commercial-Agreement.html

    GLOBENEWSWIRE
    19 Sep 2024
    Share Share
    CorMedix Inc. Announces New Commercial Agreement
    CorMedix Inc. Announces New Commercial Agreement

    09 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/09/2942984/0/en/CorMedix-Inc-Announces-New-Commercial-Agreement.html

    GLOBENEWSWIRE
    09 Sep 2024
    Share Share
    CorMedix Inc. Announces Outpatient Availability of DefenCath
    CorMedix Inc. Announces Outpatient Availability of DefenCath

    03 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/03/2908119/0/en/CorMedix-Inc-Announces-Outpatient-Availability-of-DefenCath.html

    GLOBENEWSWIRE
    03 Jul 2024
    Share Share
    CorMedix: DefenCath® Now Commercially Available In US
    CorMedix: DefenCath® Now Commercially Available In US

    15 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/15/2862768/0/en/CorMedix-Inc-Announces-U-S-Inpatient-Commercial-Availability-of-DefenCath-Taurolidine-and-Heparin.html

    GLOBENEWSWIRE
    15 Apr 2024
    Share Share
    US FDA approves CorMedix's drug for bloodstream infections
    US FDA approves CorMedix's drug for bloodstream infections

    16 Nov 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-cormedixs-antimicrobial-drug-2023-11-15/

    REUTERS
    16 Nov 2023
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.